Selected treatment-emergent adverse reactions in at least 1% of clinical trial subjects5

XIMINO | The innovative 'controlled-dose capsular' technology

Placebo-like side effects

Together, Capsular Minotab Technology and weight-based dosing allow a side effect profile similar to placebo.2,4

Clinical data of XIMINO was based on studies done with ER minocycline tablets.

Important Safety Information

  • XIMINO is contraindicated in persons who have shown hypersensitivity to any of the tetracyclines.
  • Minocycline may cause central nervous system side effects including light-headedness, dizziness, or vertigo. Advise patients.

Please see the full Important Safety Information for additional warnings and precautions.

Help patients save on their XIMINO prescription

XIMINO | Rebate Card